Yakult Honsha Co. Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2012
January 28, 2013
Share
Yakult Honsha Co. Ltd. reported consolidated and non-consolidated earnings results for the nine months ended December 31, 2012. For the period, on consolidated basis, the company's net sales were ¥242,947 million compared with ¥239,978 million a year ago. Operating income was ¥17,877 million compared with ¥19,115 million a year ago. Ordinary income was ¥23,645 million compared with ¥25,296 million a year ago. Income before income taxes and minority interests was ¥22,300 million compared with ¥23,957 million a year ago. Net income was ¥14,272 million compared with ¥13,126 million a year ago.
For the period, on non-consolidated basis, the company's net sales were ¥133,180 million compared with ¥134,708 million a year ago. Operating income was ¥2,202 million compared with ¥6,469 million a year ago. Ordinary income was ¥8,475 million compared with ¥8,786 million a year ago. Net income was ¥5,674 million compared with ¥3,608 million a year ago.
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
YAKULT HONSHA CO.,LTD. 
